RVMD Net Income History: $-1.13B (FY2025)

Fiscal year	Q1	Q2	Q3	Q4
FY26	−$454M−112.6%	−$644M−160.1%	Not reported	Not reported
FY25	−$213M−84.0%	−$248M−86.0%	−$305M−95.3%	−$365M−87.5%
FY24	−$116M−70.3%	−$133M−35.5%	−$156M−44.1%	−$194M−20.7%
FY23	−$68M−18.1%	−$98M−60.6%	−$108M−47.9%	−$161M−183.7%
FY22	−$58M−55.1%	−$61M−38.2%	−$73M−38.5%	−$57M−8.0%

01—History

Net Income History

Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.

−$1.13B

YoY changeLargest recent move−126.9%in FY20Latest −88.5%

02—Ledger

Net Income, period by period

Period	Value	Change	Source
FY2025	−$1.13B	−88.5%	10-K
FY2024	−$600.0M	−37.6%	10-K
FY2023	−$436.0M	−75.1%	10-K
FY2022	−$249.0M	−33.2%	10-K
FY2021	−$187.0M	−72.9%	10-K
FY2020	−$108.2M	−126.9%	10-K
FY2019	−$47.7M	−14.1%	10-K
FY2018	−$41.8M	—	10-K

03—Questions

What is net income?

Net income can be defined as the company's total earnings or profit. It is calculated as revenues minus all expenses including cost of goods sold, operating expenses, interest, and taxes.

What is Revolution Medicines's current net income?

Revolution Medicines (RVMD) annual net income for 2025 was $-1.13B, a 88.50% decline from 2024. Revolution Medicines net income for the quarter ending June 30, 2026 was $-644.4M.

What was Revolution Medicines's net income in 2024?

Revolution Medicines annual net income for 2024 was $-600.0M, a 37.61% decline from 2023.

What was Revolution Medicines's net income in 2023?

Revolution Medicines annual net income for 2023 was $-436.0M, a 75.10% decline from 2022.

Company: Revolution Medicines
Ticker: RVMD
Sector: Healthcare
Industry: Biological Products, (No Diagnostic Substances)

Revolution Medicines Net Income 2018-2026 | RVMD

Key Statistics